(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LAPAS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

LAPAS

ST13

US500000079302106

Class

10

Filing

79302106

Registration

6688541

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/12/2025

Classification

Registered

Trademark type

Word

Nice classes

10

Filing date

12/14/2020

Registration date

04/05/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/05/2022

Last transaction

12/12/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

LAM,HAI-LY HUYNH

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Consort Medical Limited

Representatives

Charles P. Guarino Moser Taboada

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Apparatus and devices for administering pharmaceuticals and drugspatch infusion pumps sold without medicationdrug delivery patches sold without medication; mobile apparatus and devices for administering pharmaceuticals and drugspatch infusion pumps sold without medicationdrug delivery patches sold without medication; apparatus and devices for administering pharmaceuticals and drugs which can be worn by the patientmedical apparatus in the nature of infusion and injection devices for administering drugsmedical tubing for administering drugs; medical syringes; syringe stoppers specially adapted for medical syringes; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes and medical fluid injectors; sterile apparatus for the administration of pharmaceuticals and drugsmedical apparatus in the nature of infusion and injection devices for administering drugsmedical tubing for administering drugshypodermic needles; cartridges specially adapted for medical syringes; nozzles specially adapted for medical syringes; drug delivery apparatusdrug delivery cathetersimplantable drug delivery pumpselectromagnetic drug delivery apparatus for medical use in the form of patch infusion pumps sold without medication and in the form of patch insulin pumps sold without medication; oral and nasal medication dispensersaerosol dispensers for medical use; aerosol dispensers for medical purposes; structural replacement parts and fittings for all the aforesaid goods

Publications

History of USPTO decisions and trademark events.

37 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/11/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/29/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/22/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/20/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/25/2022

FIMP

FINAL DISPOSITION PROCESSED

08/25/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/05/2022

GPNX

NOTIFICATION PROCESSED BY IB

01/29/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/18/2022

PUBO

PUBLISHED FOR OPPOSITION

01/18/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/29/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/29/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/29/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/13/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

11/24/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/24/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

11/24/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/24/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/23/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/23/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/23/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/04/2021

GNFR

FINAL REFUSAL E-MAILED

08/04/2021

CNFR

FINAL REFUSAL WRITTEN

08/04/2021

RFNT

REFUSAL PROCESSED BY IB

07/11/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/09/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/09/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/15/2021

RFRR

REFUSAL PROCESSED BY MPU

06/15/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/11/2021

CNRT

NON-FINAL ACTION WRITTEN

06/10/2021

DOCK

ASSIGNED TO EXAMINER

06/07/2021

MAFR

APPLICATION FILING RECEIPT MAILED

01/15/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/11/2021

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

01/07/2021

Continuous trademark protection

Get notified about every new filing that threatens LAPAS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.